2024 Q1 Form 10-K Financial Statement

#000147793224001711 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023
Revenue $3.190M $12.60M
YoY Change 7.08% 49.09%
Cost Of Revenue $2.666M $8.981M
YoY Change 20.05% 58.43%
Gross Profit $524.5K $3.620M
YoY Change -30.87% 30.08%
Gross Profit Margin 16.44% 28.73%
Selling, General & Admin $790.9K $2.782M
YoY Change -16.05% 153.25%
% of Gross Profit 150.79% 76.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $160.5K $449.0K
YoY Change 12.69% 91.87%
% of Gross Profit 30.61% 12.4%
Operating Expenses $1.155M $4.011M
YoY Change -7.1% 122.57%
Operating Profit -$630.8K -$391.2K
YoY Change 30.09% -139.89%
Interest Expense $27.49K $114.8K
YoY Change -47.96% -33.61%
% of Operating Profit
Other Income/Expense, Net -$80.65K
YoY Change
Pretax Income -$563.2K -$742.3K
YoY Change 9.84% -191.88%
Income Tax $117.5K -$180.0K
% Of Pretax Income
Net Earnings -$445.7K -$562.3K
YoY Change 31.96% -192.5%
Net Earnings / Revenue -13.97% -4.46%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.07 -$0.09
COMMON SHARES
Basic Shares Outstanding 6.246M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.127M $8.145M
YoY Change -24.78% -34.24%
Cash & Equivalents $4.668M
Short-Term Investments $1.458M $5.994M
Other Short-Term Assets $336.6K $483.9K
YoY Change -30.45% 1679.77%
Inventory $226.2K $158.4K
Prepaid Expenses
Receivables $13.26K $76.95K
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.703M $8.864M
YoY Change -24.39% -29.45%
LONG-TERM ASSETS
Property, Plant & Equipment $3.225M $5.299M
YoY Change -2.1% 232.8%
Goodwill $671.2K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $928.3K $1.369M
YoY Change -32.2% 1725.59%
Other Assets $372.3K $111.9K
YoY Change 232.69% -59.13%
Total Long-Term Assets $7.299M $7.906M
YoY Change -7.68% 307.26%
TOTAL ASSETS
Total Short-Term Assets $6.703M $8.864M
Total Long-Term Assets $7.299M $7.906M
Total Assets $14.00M $16.77M
YoY Change -16.51% 15.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $629.5K $448.6K
YoY Change 40.32% 53.65%
Accrued Expenses $399.9K $726.0K
YoY Change -24.9% 185.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $791.4K
YoY Change -100.0%
Long-Term Debt Due $171.8K $167.6K
YoY Change 2.49% -1.35%
Total Short-Term Liabilities $1.415M $2.134M
YoY Change -33.67% 130.58%
LONG-TERM LIABILITIES
Long-Term Debt $2.238M $2.658M
YoY Change -15.83% -6.16%
Other Long-Term Liabilities $1.551M $1.825M
YoY Change -14.99% -6083633.33%
Total Long-Term Liabilities $2.238M $4.484M
YoY Change -15.83% 58.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.415M $2.134M
Total Long-Term Liabilities $2.238M $4.484M
Total Liabilities $5.204M $6.617M
YoY Change -21.35% 70.66%
SHAREHOLDERS EQUITY
Retained Earnings -$2.496M
YoY Change 114.67%
Common Stock $12.49K
YoY Change -2.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.797M $10.15M
YoY Change
Total Liabilities & Shareholders Equity $14.00M $16.77M
YoY Change -16.51% 15.61%

Cashflow Statement

Concept 2024 Q1 2023
OPERATING ACTIVITIES
Net Income -$445.7K -$562.3K
YoY Change 31.96% -192.5%
Depreciation, Depletion And Amortization $160.5K $449.0K
YoY Change 12.69% 91.87%
Cash From Operating Activities -$408.9K $211.8K
YoY Change 49.94% -73.98%
INVESTING ACTIVITIES
Capital Expenditures $112.4K $478.4K
YoY Change -12.63% 130.09%
Acquisitions $1.150M
YoY Change
Other Investing Activities $50.10K -$8.250M
YoY Change -100.95%
Cash From Investing Activities -$62.32K -$11.04M
YoY Change -98.84% 5208.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $45.06K $168.5K
YoY Change -94.89%
Cash From Financing Activities -$161.0K $590.7K
YoY Change -125.09% -94.35%
NET CHANGE
Cash From Operating Activities -$408.9K $211.8K
Cash From Investing Activities -$62.32K -$11.04M
Cash From Financing Activities -$161.0K $590.7K
Net Change In Cash -$632.2K -$10.24M
YoY Change -87.4% -192.5%
FREE CASH FLOW
Cash From Operating Activities -$408.9K $211.8K
Capital Expenditures $112.4K $478.4K
Free Cash Flow -$521.3K -$266.6K
YoY Change 29.88% -143.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Inventory Net
InventoryNet
201333 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
158351 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47246 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37397 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1392060 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5994295 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
28737 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
76948 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
446524 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7228573 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8864093 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3247013 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3294644 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1789285 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2004673 usd
CY2023Q4 us-gaap Investments
Investments
1022806 usd
CY2023Q1 us-gaap Investments
Investments
1369186 usd
CY2023Q1 us-gaap Goodwill
Goodwill
671220 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
395113 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
453978 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
49202 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
50903 usd
CY2023Q4 us-gaap Assets
Assets
14609212 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
555247 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
448605 usd
CY2023Q4 btbd Broker Margin Loan
BrokerMarginLoan
115899 usd
CY2023Q1 btbd Broker Margin Loan
BrokerMarginLoan
791370 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
167616 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
215326 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
193430 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
480289 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
532520 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
61000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
671220 usd
CY2023Q1 us-gaap Assets
Assets
16769697 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1550090 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1825057 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5420483 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6617075 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12492 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
12792 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11583235 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11409235 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2049891 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1162523 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9188729 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001718224
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6461118 shares
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 btbd Common Shares Reserved For Issuance
CommonSharesReservedForIssuance
100000 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-233233
CY2023 dei Entity Registrant Name
EntityRegistrantName
BT BRANDS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1495764
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
405 Main Avenue West
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2D
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
West Fargo
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
ND
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
58078
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.002 par value
CY2023 dei Trading Symbol
TradingSymbol
BTBD
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei City Area Code
CityAreaCode
307
CY2023 dei Local Phone Number
LocalPhoneNumber
274-3055
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
5949784 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6246118 shares
CY2023 dei Auditor Name
AuditorName
Boulay PLLP
CY2023 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2023 dei Auditor Firm
AuditorFirmId
542
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5300446 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
206000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
183329 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2133541 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2269771 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2658477 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1600622 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6461118 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6246118 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6396118 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
357107 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
106882 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10152622 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14609212 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16769697 usd
CY2023 us-gaap Revenues
Revenues
14076653 usd
CY2023 us-gaap Revenues
Revenues
12601169 usd
CY2023 btbd Food And Paper Costs
FoodAndPaperCosts
5597167 usd
CY2023 btbd Food And Paper Costs
FoodAndPaperCosts
4854321 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5458351 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4126837 usd
CY2023 us-gaap Occupancy Net
OccupancyNet
1312717 usd
CY2023 us-gaap Occupancy Net
OccupancyNet
1147744 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
841894 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
780564 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
598540 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
449038 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1650755 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1633829 usd
CY2023 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
310182 usd
CY2023 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
15149242 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
12992333 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1072589 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-391164 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
80139 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-86422 usd
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
300923 usd
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
125529 usd
CY2023 us-gaap Interest Expense
InterestExpense
97608 usd
CY2023 us-gaap Interest Expense
InterestExpense
114766 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
103848 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80649 usd
CY2023 btbd Equity In Net Loss Of Affiliate
EquityInNetLossOfAffiliate
-347081 usd
CY2023 btbd Equity In Net Loss Of Affiliate
EquityInNetLossOfAffiliate
-194813 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1032368 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-742285 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
180000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-887368 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-562285 usd
CY2023 btbd Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.14
CY2023 btbd Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.09
CY2023 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6261631 shares
CY2023 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6455379 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10628353 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
118700 usd
CY2023 btbd Shares Issued In Exercise Of Warrants Amount
SharesIssuedInExerciseOfWarrantsAmount
74866 usd
CY2023 btbd Treasury Stock Purchase Amount
TreasuryStockPurchaseAmount
-107012 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-562285 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10152622 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
174000 usd
CY2023 btbd Treasury Stock Purchase Amount
TreasuryStockPurchaseAmount
-250525 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-887368 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9188729 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-887368 usd
CY2023 btbd Loan Forgiveness
LoanForgiveness
0 usd
CY2023 btbd Loan Forgiveness
LoanForgiveness
-13750 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
174000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
118700 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-562285 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
598540 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449038 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5400 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5400 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-145000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-180000 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-80139 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
86422 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-23058 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-47708 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
346380 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
194813 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-310182 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
12849 usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
13814 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-181339 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
48211 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4697 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-42982 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22851 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9849 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10211 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
106642 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
156632 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
129108 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
237569 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-209088 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-258787 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
211798 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1150000 usd
CY2023 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
0 usd
CY2023 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
1159600 usd
CY2023 btbd Investment In Village Bier Garten
InvestmentInVillageBierGarten
0 usd
CY2023 btbd Investment In Village Bier Garten
InvestmentInVillageBierGarten
690000 usd
CY2023 btbd Investment In Bagger Daves Burger Tavern Inc
InvestmentInBaggerDavesBurgerTavernInc
0 usd
CY2023 btbd Investment In Bagger Daves Burger Tavern Inc
InvestmentInBaggerDavesBurgerTavernInc
1259999 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
496000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
488388 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478396 usd
CY2023 btbd Investment In Related Company
InvestmentInRelatedCompany
0 usd
CY2023 btbd Investment In Related Company
InvestmentInRelatedCompany
229000 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
532403 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
25662523 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5237835 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
19629514 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
37543 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4713044 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11037547 usd
CY2023 btbd Broker Margin Loan Reduction
BrokerMarginLoanReduction
-675471 usd
CY2023 btbd Broker Margin Loan Reduction
BrokerMarginLoanReduction
791370 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
378393 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
168529 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
74866 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
250525 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
107012 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1304389 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
590695 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3149868 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10235054 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12385632 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5300446 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
85923 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
109366 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
209088 usd
CY2023Q2 btbd Common Shares
CommonShares
11095085 shares
CY2022Q2 btbd Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
0.412 pure
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1260000 usd
CY2022Q2 btbd Warrant Excercise Price
WarrantExcercisePrice
0.11
CY2023Q4 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
438500 usd
CY2023Q1 btbd Marketables Securities Current
MarketablesSecuritiesCurrent
5000000 usd
CY2023 btbd Short Term Investment Description
ShortTermInvestmentDescription
Treasury Bills maturing March 16, 2023, purchased for $4,907,378 in August 2022
CY2023Q4 btbd Total Broker Margin Loan
TotalBrokerMarginLoan
115899 usd
CY2023Q1 btbd Total Broker Margin Loan
TotalBrokerMarginLoan
791372 usd
CY2023 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.068 pure
CY2023 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.046 pure
CY2023 btbd Unpaid Property Taxes
UnpaidPropertyTaxes
180000 usd
CY2023 btbd Accrued Expense
AccruedExpense
100000 usd
CY2023 btbd Estimated Useful Life Of The Acquired Dairy Queen
EstimatedUsefulLifeOfTheAcquiredDairyQueen
P14Y
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
81594 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
76701 usd
CY2023 btbd Warrant Exercised
WarrantExercised
2746838 shares
CY2023 btbd Warrant Excercise Price
WarrantExcercisePrice
5.50
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and the differences could be significant.</p>
CY2023Q4 us-gaap Land
Land
435239 usd
CY2023Q1 us-gaap Land
Land
485239 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3994685 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3893274 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2463626 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2402157 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6893550 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6780670 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3387786 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3039500 usd
CY2023Q4 btbd Less Property Held For Sale
LessPropertyHeldForSale
-258751 usd
CY2023Q1 btbd Less Property Held For Sale
LessPropertyHeldForSale
-446526 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3247013 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3294644 usd
CY2023 us-gaap Depreciation
Depreciation
539675 usd
CY2023 us-gaap Depreciation
Depreciation
412016 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
491000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-95887 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
395113 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
491000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-37022 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
453978 usd
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2023 us-gaap Exploration Expense
ExplorationExpense
58865 usd
CY2022 us-gaap Exploration Expense
ExplorationExpense
37022 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
289076 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
297909 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
306038 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
258184 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
208895 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
828390 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2188492 usd
CY2023Q4 btbd Operating Leases Future Minimum Interest
OperatingLeasesFutureMinimumInterest
-372544 usd
CY2023Q4 btbd Present Value Of Lease Payments
PresentValueOfLeasePayments
1815948 usd
CY2023 btbd Lease Weighted Average Remaining Lease Term
LeaseWeightedAverageRemainingLeaseTerm
P5Y3M18D
CY2023 btbd Incremental Borrowing Rate
IncrementalBorrowingRate
0.0432 pure
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
298567 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
239092 usd
CY2023 us-gaap Short Term Lease Payments
ShortTermLeasePayments
282000 usd
CY2023 us-gaap Short Term Lease Payments
ShortTermLeasePayments
207000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
16500 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
17000 usd
CY2023 btbd Monthly Rent
MonthlyRent
1900 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1700000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2000000.0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
206000 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
61000 usd
CY2023Q4 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Property And Equipment Tax
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPropertyAndEquipmentTax
-349000 usd
CY2023Q1 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Property And Equipment Tax
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPropertyAndEquipmentTax
-445000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
78000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
34000 usd
CY2023Q4 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Goodwill Deducted For Tax Purposes
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsGoodwillDeductedForTaxPurposes
-17000 usd
CY2023Q1 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Goodwill Deducted For Tax Purposes
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsGoodwillDeductedForTaxPurposes
-9000 usd
CY2023Q4 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Unrealized Gain Loss On Investments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsUnrealizedGainLossOnInvestments
2000 usd
CY2023Q1 btbd Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Unrealized Gain Loss On Investments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsUnrealizedGainLossOnInvestments
19000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
23000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
22000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
12000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
49000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
78000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
421000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
349000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
206000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
61000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-145000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-180000 usd
CY2023 btbd Income Tax Expenses Benefit
IncomeTaxExpensesBenefit
-145000 usd
CY2023 btbd Income Tax Expenses Benefit
IncomeTaxExpensesBenefit
-180000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-216000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-160000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-36000 usd
CY2023 btbd Fair Value Of Options Granted During The Period
FairValueOfOptionsGrantedDuringThePeriod
1.60
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-35000 usd
CY2023 btbd Equity In Loss Of Unconsolidated Subsidiary
EquityInLossOfUnconsolidatedSubsidiary
85000 usd
CY2023 btbd Equity In Loss Of Unconsolidated Subsidiary
EquityInLossOfUnconsolidatedSubsidiary
40000 usd
CY2023 btbd Other
Other
22000 usd
CY2023 btbd Other
Other
-25000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-145000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-180000 usd
CY2023Q4 btbd Accrued Real Estate Taxes
AccruedRealEstateTaxes
49357 usd
CY2023Q1 btbd Accrued Real Estate Taxes
AccruedRealEstateTaxes
202436 usd
CY2023Q4 btbd Accrued Bonus Compensation
AccruedBonusCompensation
119139 usd
CY2023Q1 btbd Accrued Bonus Compensation
AccruedBonusCompensation
59139 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
149587 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
143481 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
11343 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
12764 usd
CY2023Q4 btbd Accrued Sales Taxes Payable
AccruedSalesTaxesPayable
81683 usd
CY2023Q1 btbd Accrued Sales Taxes Payable
AccruedSalesTaxesPayable
70270 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
17663 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
17663 usd
CY2023Q4 btbd Accured Gift Card Liability
AccuredGiftCardLiability
26844 usd
CY2023Q1 btbd Accured Gift Card Liability
AccuredGiftCardLiability
25965 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24673 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
802 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
480289 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
532520 usd
CY2023 btbd Term Of Warrant
TermOfWarrant
five-year
CY2023 btbd Warrant Exercised
WarrantExercised
13612 shares
CY2023 btbd Fairvfair Value Of Warrantalueofwarrant
FairvfairValueOfWarrantalueofwarrant
74866 usd
CY2023Q4 btbd Treasury Shares For Future Issuance
TreasurySharesForFutureIssuance
215000 shares
CY2023Q1 btbd Treasury Shares For Future Issuance
TreasurySharesForFutureIssuance
65000 shares
CY2023 btbd Common Shares Reserved For Issuance
CommonSharesReservedForIssuance
250000 shares
CY2023 btbd Shares Available For A Grant
SharesAvailableForAGrant
779750 shares
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
15000 shares
CY2021 btbd Exercisable Price
ExercisablePrice
5
CY2022 btbd Granted Options To Purchase
GrantedOptionsToPurchase
216000 shares
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
175000 shares
CY2022 btbd Purchase Price Per Shares
PurchasePricePerShares
2.58
CY2023 btbd Description Of Consultant Warrants Purchase
DescriptionOfConsultantWarrantsPurchase
consultant warrants to purchase 100,000 shares at $2.50 per share for seven years with the option vesting warrants vesting monthly over five years
CY2023 btbd Descrition Of Consulting Agreement
DescritionOfConsultingAgreement
we project that approximately $144,000 in stock based compensation will recognized at the rate of $32,000 per year in each of the four years and $16,000 in 2028
CY2023 btbd Compensation Expenses
CompensationExpenses
174000 usd
CY2023 btbd Compensation Expenses
CompensationExpenses
118700 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
120000 usd
CY2023Q1 btbd Granted Options To Purchase
GrantedOptionsToPurchase
250000 shares
CY2023Q1 btbd Purchase Price Per Shares
PurchasePricePerShares
8.50
CY2023Q1 btbd Trading Days
TradingDays
twenty consecutive
CY2023 btbd Fair Value Of Options Granted During The Period
FairValueOfOptionsGrantedDuringThePeriod
1.39
CY2023 btbd Expected Life In Years
ExpectedLifeInYears
P6Y
CY2023 btbd Expected Life In Years
ExpectedLifeInYears
P4Y9M29D
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2023 btbd Expected Stock Volatility
ExpectedStockVolatility
0.63 pure
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
105000 usd
CY2023 btbd Expected Stock Volatility
ExpectedStockVolatility
0.63 pure
CY2023 btbd Risk Free Interest Rate
RiskFreeInterestRate
0.0375 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.00
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
216000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedTerm
P9Y3M18D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10750 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.58
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P9Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
56250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.23
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P9Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.50
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedTerm
P6Y2M12D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.58
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319250 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2023 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P7Y7M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
106702 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.85
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023 btbd Risk Free Interest Rate
RiskFreeInterestRate
0.02 pure
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2489299 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2864484 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-36199 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-41599 usd
CY2023Q4 btbd Current Maturities Notes Payable
CurrentMaturitiesNotesPayable
-183329 usd
CY2023Q1 btbd Current Maturities Notes Payable
CurrentMaturitiesNotesPayable
-167616 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2269771 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2658477 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
183329 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
189829 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
196502 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
203410 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
210519 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1581299 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2489299 usd
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08 pure
CY2023Q4 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
34697 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.65

Files In Submission

Name View Source Status
0001477932-24-001711-index-headers.html Edgar Link pending
0001477932-24-001711-index.html Edgar Link pending
0001477932-24-001711.txt Edgar Link pending
0001477932-24-001711-xbrl.zip Edgar Link pending
btbd-20231231.xsd Edgar Link pending
btbd_10k.htm Edgar Link pending
btbd_10kimg1.jpg Edgar Link pending
btbd_ex191.htm Edgar Link pending
btbd_ex211.htm Edgar Link pending
btbd_ex311.htm Edgar Link pending
btbd_ex312.htm Edgar Link pending
btbd_ex321.htm Edgar Link pending
btbd_ex322.htm Edgar Link pending
btbd_ex44.htm Edgar Link pending
btbd_ex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
btbd-20231231_def.xml Edgar Link unprocessable
btbd-20231231_lab.xml Edgar Link unprocessable
btbd-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
btbd_10k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
btbd-20231231_cal.xml Edgar Link unprocessable